![Bioorthogonally Activatable Base Editing for On-Demand Pyroptosis | Journal of the American Chemical Society Bioorthogonally Activatable Base Editing for On-Demand Pyroptosis | Journal of the American Chemical Society](https://pubs.acs.org/cms/10.1021/jacs.1c12924/asset/images/medium/ja1c12924_0007.gif)
Bioorthogonally Activatable Base Editing for On-Demand Pyroptosis | Journal of the American Chemical Society
![Cells | Free Full-Text | BE4max and AncBE4max Are Efficient in Germline Conversion of C:G to T:A Base Pairs in Zebrafish Cells | Free Full-Text | BE4max and AncBE4max Are Efficient in Germline Conversion of C:G to T:A Base Pairs in Zebrafish](https://www.mdpi.com/cells/cells-09-01690/article_deploy/html/images/cells-09-01690-g001.png)
Cells | Free Full-Text | BE4max and AncBE4max Are Efficient in Germline Conversion of C:G to T:A Base Pairs in Zebrafish
![Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects | Signal Transduction and Targeted Therapy Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects | Signal Transduction and Targeted Therapy](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41392-019-0089-y/MediaObjects/41392_2019_89_Fig1_HTML.png)
Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects | Signal Transduction and Targeted Therapy
![In situ CRISPR‐Cas9 base editing for the development of genetically engineered mouse models of breast cancer | The EMBO Journal In situ CRISPR‐Cas9 base editing for the development of genetically engineered mouse models of breast cancer | The EMBO Journal](https://www.embopress.org/cms/asset/45c60bf4-5504-4ddf-bf10-aeda271d206e/embj2019102169-abs-0001-m.jpg)
In situ CRISPR‐Cas9 base editing for the development of genetically engineered mouse models of breast cancer | The EMBO Journal
![CRISPR Start-Loss: A Novel and Practical Alternative for Gene Silencing through Base-Editing-Induced Start Codon Mutations: Molecular Therapy - Nucleic Acids CRISPR Start-Loss: A Novel and Practical Alternative for Gene Silencing through Base-Editing-Induced Start Codon Mutations: Molecular Therapy - Nucleic Acids](https://www.cell.com/cms/asset/a27f0a76-a242-49dd-98f8-02538830e3bd/fx1.jpg)
CRISPR Start-Loss: A Novel and Practical Alternative for Gene Silencing through Base-Editing-Induced Start Codon Mutations: Molecular Therapy - Nucleic Acids
![CRISPR base editing and prime editing: DSB and template-free editing systems for bacteria and plants - ScienceDirect CRISPR base editing and prime editing: DSB and template-free editing systems for bacteria and plants - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2405805X20300624-gr1.jpg)
CRISPR base editing and prime editing: DSB and template-free editing systems for bacteria and plants - ScienceDirect
CRISPR-Mediated Base Editing Enables Efficient Disruption of Eukaryotic Genes through Induction of STOP Codons
![CRISPR-Cas9 Genome Editing for Treatment of Atherogenic Dyslipidemia | Arteriosclerosis, Thrombosis, and Vascular Biology CRISPR-Cas9 Genome Editing for Treatment of Atherogenic Dyslipidemia | Arteriosclerosis, Thrombosis, and Vascular Biology](https://www.ahajournals.org/cms/asset/bd747fd7-7b95-4ad3-832a-5c90e8da6b65/7ga01.jpg)